Nicolien C. de Clercq

Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen et al. · Clinical Cancer Research · 2021 · 267 citations · Full text

Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study

Nicolien C. de Clercq, Tom van den Ende, Andrei Prodan et al. · Clinical Cancer Research · 2021 · 64 citations · Full text

The intestinal microbiota, energy balance, and malnutrition: emphasis on the role of short-chain fatty acids

Kristina S. Fluitman, Nicolien C. de Clercq, Bart J. F. Keijser et al. · Expert Review of Endocrinology & Metabolism · 2017 · 42 citations · Full text

A phase II feasibility trial of neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: The PERFECT trial.

Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen et al. · Journal of Clinical Oncology · 2019 · 24 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +16

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects

Guido J. Bakker, Johan G. Schnitzler, Siroon Bekkering et al. · Physiological Reports · 2019 · 16 citations · Full text